Back to search

Article

Correlation Between Platelet Indices and Residual Cancer Burden Score in Patients with Locally Advanced Luminal B HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

2026-07-21

Abstract excerpt

<title>Abstract</title> <p>Background Luminal B HER2-negative breast cancer often shows an incomplete pathological response after neoadjuvant chemotherapy. Residual Cancer Burden (RCB) is a standardized histopathological tool used to quantify post-treatment residual disease and has prognostic value after neoadjuvant therapy. Platelets interact with tumor cells through inflammatory, angiogenic, and metastatic pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb7af0d7-1742-5cc6-b5a3-0a670c9dfef1
DOI
10.21203/rs.3.rs-10310233/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Correlation Between Platelet Indices and Residual Cancer Burden Score in Patients with Locally Advanced Luminal B HER2-Negative Breast Cancer Receiving Neoadjuvant ChemotherapyDOI 10.21203/rs.3.rs-10310233/v1
Select a neighboring publication to make it the new centre.